Calling all media inquiries! Pay attention to our recent findings and give us a call to talk to the expert directly. Contact Liz Moore to schedule some time to get insightful, unbiased, fact-based answers to your questions.
New research from Avalere finds that despite the innovation of abuse-deterrent properties and labeling for branded opioids, Medicare Part D plan coverage for these products is declining rapidly.
Avalere Health today announced the hiring of Nancy McGee as executive vice president to head its thriving life sciences business unit.
Avalere director, Leigh Ann Bruhn, was recently named to the Academy of Managed Care Pharmacy’s (AMCP) Corporate Member Council.
Avalere director Dr. Lakshman Ramamurthy will be a panelist on the Centers for Medicare and Medicaid Services’ (CMS) Medicare Evidence Development and Coverage Advisory Committee (MEDCAC), which will meet on Tuesday, March 24.
Lisa Latts, MD, and Rick Smith join Avalere's team.
In 2015, Avalere Health and the Center for Medical Technology Policy will work together to develop the Partnership for Enhanced Recovery to promote broader adoption of proven protocols in the surgical space across a number of US hospitals.
Sheahan will lead Avalere Communications, a rapidly growing group within Avalere Health that brings deep substantive and innovative strategic thinking to healthcare communications.
Avalere-Pope Woodhead collaboration a natural fit to deliver global market services
Avalere Health announced today that Lindy Hinman will be re-joining the company as senior vice president, leading its Health Plans and Managed Care Practice.
New team members add depth and experience across multiple health policy issues.
Lakshman Ramamurthy, PhD, director of FDA & Regulatory Policy at Avalere Health, has been appointed by the Centers for Medicare and Medicaid (CMS) to serve as an industry representative to the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC).
Avalere will be hosting a conference on the future of market access for diagnostics and personalized medicine.
Many of Avalere's experts are heading north to Canada for ISPOR's 19th Annual International Meeting, where we'll have several panel discussions and poster presentations.
Avalere is pleased to announce a new formalized collaboration with Michael “Buz” Waitzkin.
This month, Avalere Health proudly joins the Health Data Consortium (HDC), an organization comprising government, private sector, and non-for-profit entities, whose goal is to improve health and healthcare by advancing the availability and innovative use of data.